Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6702796 | 0.93 | BCAT2 (0.37) | BCAT2BCAT1 | |
| SCHEMBL6696728 | 0.88 | BCAT2 (0.32) | BCAT2BCAT1 | |
| SCHEMBL6702752 | 0.83 | BCAT2 (0.33) | BCAT2BCAT1 | |
| SCHEMBL7911705 | 0.83 | BCAT2 (0.32) | BCAT2BCAT1 | |
| SCHEMBL7592627 | 0.83 | BCAT2 (0.39) | BCAT2BCAT1 | |
| SCHEMBL7099437 | 0.83 | BCAT1 (0.55) | BCAT2BCAT1 | |
| SCHEMBL6697595 | 0.82 | MAPT (0.36) | BCAT2BCAT1 | |
| SCHEMBL8672663 | 0.81 | BCAT2 (0.32) | BCAT2BCAT1 | |
| SCHEMBL6698076 | 0.80 | BCAT2 (0.32) | BCAT2BCAT1 | |
| SCHEMBL6699122 | 0.79 | BCAT2 (0.33) | BCAT2BCAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040171488-A1 | N-aryl-uracils based Herbicides | FEUCHT DIETER (DE) | 2004-09-02 | — | — | US | disclosed |
| US-6734139-B1 | N-aryl-uracile-based herbicides | BAYER AKTIENGESELLSCHAFT (DE) | 2004-05-11 | — | — | US | disclosed |
| US-20030032807-A1 | Method for the production of 1-amino -3-aryl -uracils | BAYER AKTIENGESELLSCHAFT (DE) | 2003-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030032807-A1 | Method for the production of 1-amino -3-aryl -uracils | NQO2, QARS1, NUDT1 | BCAT2 451/4885BCAT1 378/4885 |
| US-20040171488-A1 | N-aryl-uracils based Herbicides | DDT, UNG, DDC | BCAT2 552/4885BCAT1 475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.